| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,305 |
14,065 |
$897K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,935 |
5,316 |
$532K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,298 |
5,238 |
$486K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,599 |
4,207 |
$371K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,277 |
9,126 |
$129K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,188 |
1,107 |
$92K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,664 |
2,537 |
$91K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
864 |
765 |
$69K |
| 99215 |
Prolong outpt/office vis |
424 |
374 |
$60K |
| 90698 |
|
3,304 |
2,998 |
$52K |
| 90670 |
|
2,972 |
2,653 |
$49K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
463 |
452 |
$46K |
| 90686 |
|
2,732 |
2,474 |
$43K |
| 99188 |
|
1,879 |
1,721 |
$33K |
| 87631 |
|
331 |
250 |
$24K |
| 90658 |
|
991 |
979 |
$18K |
| 90657 |
|
714 |
691 |
$13K |
| 90680 |
|
803 |
720 |
$13K |
| 90677 |
|
759 |
724 |
$10K |
| 90633 |
|
517 |
455 |
$8K |
| 90744 |
|
472 |
425 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
212 |
191 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
129 |
128 |
$6K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
50 |
46 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
334 |
321 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
355 |
215 |
$5K |
| 90651 |
|
332 |
286 |
$5K |
| 90656 |
|
458 |
458 |
$5K |
| 90716 |
|
284 |
247 |
$4K |
| 90707 |
|
276 |
246 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
288 |
280 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
101 |
100 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
52 |
49 |
$3K |
| 99460 |
|
30 |
27 |
$3K |
| 85018 |
|
1,365 |
1,210 |
$3K |
| 90619 |
|
138 |
116 |
$2K |
| 80061 |
Lipid panel |
176 |
156 |
$2K |
| 99462 |
|
29 |
26 |
$1K |
| 81003 |
|
516 |
477 |
$1K |
| 90715 |
|
55 |
55 |
$1K |
| 83655 |
|
63 |
60 |
$783.78 |
| 90734 |
|
26 |
25 |
$466.78 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
24 |
$351.33 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$332.10 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$249.38 |
| 90696 |
|
12 |
12 |
$173.52 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
367 |
326 |
$73.19 |
| 36416 |
|
1,351 |
1,145 |
$10.30 |
| 3008F |
|
1,184 |
1,163 |
$4.63 |
| 96161 |
|
346 |
337 |
$4.37 |
| 99000 |
|
175 |
166 |
$0.00 |
| 90461 |
|
77 |
66 |
$0.00 |